advertisement
Acta neuropathologica communications 37
Showing records 1 to 25 | Display all abstracts in Acta neuropathologica communications120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Cimaglia G
Acta neuropathologica communications 2024; 12: 137
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Huang KC
Acta neuropathologica communications 2024; 12: 164
119550 Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
Thananthirige KPM
Acta neuropathologica communications 2024; 12: 89
122381 Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model
Reboussin É
Acta neuropathologica communications 2024; 12: 150
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Gomes C
Acta neuropathologica communications 2024; 12: 164
119550 Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
Chitranshi N
Acta neuropathologica communications 2024; 12: 89
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Tribble JR
Acta neuropathologica communications 2024; 12: 137
122381 Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model
Bastelica P; Benmessabih I
Acta neuropathologica communications 2024; 12: 150
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Shiga Y
Acta neuropathologica communications 2024; 12: 164
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Votruba M
Acta neuropathologica communications 2024; 12: 137
119550 Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
Basavarajappa D; Rajput R
Acta neuropathologica communications 2024; 12: 89
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Williams PA
Acta neuropathologica communications 2024; 12: 137
122381 Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model
Cordovilla A
Acta neuropathologica communications 2024; 12: 150
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Belforte N; VanderWall KB
Acta neuropathologica communications 2024; 12: 164
122381 Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model
Delarasse C
Acta neuropathologica communications 2024; 12: 150
120162 Oral nicotinamide provides robust, dose-dependent structural and metabolic neuroprotection of retinal ganglion cells in experimental glaucoma
Morgan JE
Acta neuropathologica communications 2024; 12: 137
119550 Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
Abbasi M
Acta neuropathologica communications 2024; 12: 89
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
VanderWall KB
Acta neuropathologica communications 2024; 12: 164
122381 Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model
Réaux-Le Goazigo A
Acta neuropathologica communications 2024; 12: 150
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Lavekar SS
Acta neuropathologica communications 2024; 12: 164
119550 Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
Palanivel V; Gupta VB
Acta neuropathologica communications 2024; 12: 89
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Fligor CM
Acta neuropathologica communications 2024; 12: 164
122381 Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model
Brignole-Baudouin F
Acta neuropathologica communications 2024; 12: 150
123196 Acquisition of neurodegenerative features in isogenic OPTN(E50K) human stem cell-derived retinal ganglion cells associated with autophagy disruption and mTORC1 signaling reduction
Harkin J
Acta neuropathologica communications 2024; 12: 164
119550 Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype
Paulo JA
Acta neuropathologica communications 2024; 12: 89
